Cook’s Zenith TX2 graft approval
This article was originally published in The Gray Sheet
Executive Summary
Cook gains PMA approval for its Zenith TX2 thoracic aortic aneurysm endovascular graft. The device is indicated for patients with "aneurysms or ulcers of the descending thoracic aorta having vascular morphology suitable for endovascular repair," according to Cook. The company completed its modular PMA submission last August and announced approval May 23. Gore's TAG TAA device was approved in 2005; and Medtronic is seeking approval for its Talent TAA graft (1"The Gray Sheet" Aug. 13, 2007, In Brief)
You may also be interested in...
Zenith TX2 graft
Cook projects first quarter 2008 U.S. launch of its Zenith TX2 thoracic aortic aneurysm endovascular graft following submission to FDA of the final PMA module, announced Aug. 7. The PMA includes data from the 230-patient STARZ-TX2 trial, which was presented at the Society for Vascular Surgery conference in Baltimore June 9. Zenith's TX2 is already available in Europe, Australia and New Zealand. Gore's TAG TAA device was approved in 2005, and Medtronic is seeking approval for its Talent TAA graft (1"The Gray Sheet" Jan. 1, 2006, In Brief)...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.